BI 765845: Heart disease modulator | Myocardial infarction
Phase 2
Therapeutic Area: Cardio-renal-metabolic Diseases
Indication: Myocardial infarction
Anchored in external partnership or acquisition
This compound is under investigation, further information will be available soon.